Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (211-220 of 531) with videos related to

Pageof 54
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 9, 2019
A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremiaSarah C J Jorgensen, Abdalhamid M Lagnf, Sahil Bhatia, et al.
Pharmacotherapy|December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic CombinationsTaylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremiaM J Rybak, E M Bailey, K C Lamp, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2007
Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureusJudy N Chin, Michael J Rybak, Chrissy M Cheung, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelB J McGrath, E M Bailey, K C Lamp, et al.
American Journal of Infection Control|September 22, 2015
Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?Kimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Pharmacotherapy|April 30, 1999
Outcome assessment of minimizing vancomycin monitoring and dosing adjustmentsC M Karam, P S McKinnon, M M Neuhauser, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection modelD M Cappelletty, S L Kang, S M Palmer, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosaK C Lamp, M J Rybak, B J McGrath, et al.
Annals of Surgery|November 1, 1976
Effect of irradiation on the canine exocrine pancreasP L Pieroni, J Rudick, M Adler, et al.
Pageof 54

Showing results (211-220 of 531) with videos related to

Sort By:
Pageof 54
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 9, 2019
A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremiaSarah C J Jorgensen, Abdalhamid M Lagnf, Sahil Bhatia, et al.
Pharmacotherapy|December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic CombinationsTaylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremiaM J Rybak, E M Bailey, K C Lamp, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2007
Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureusJudy N Chin, Michael J Rybak, Chrissy M Cheung, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelB J McGrath, E M Bailey, K C Lamp, et al.
American Journal of Infection Control|September 22, 2015
Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?Kimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Pharmacotherapy|April 30, 1999
Outcome assessment of minimizing vancomycin monitoring and dosing adjustmentsC M Karam, P S McKinnon, M M Neuhauser, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection modelD M Cappelletty, S L Kang, S M Palmer, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosaK C Lamp, M J Rybak, B J McGrath, et al.
Annals of Surgery|November 1, 1976
Effect of irradiation on the canine exocrine pancreasP L Pieroni, J Rudick, M Adler, et al.
Pageof 54